Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD

Last updated: November 25, 2015
Sponsor: Ain Shams University
Overall Status: Trial Status Unknown

Phase

1/2

Condition

Menstrual Disorders

Dysfunctional Uterine Bleeding

Female Hormonal Deficiencies/abnormalities

Treatment

N/A

Clinical Study ID

NCT02616731
TXAvsDiosmin-IUDmenorrhagia
  • Ages 20-40
  • Female
  • Accepts Healthy Volunteers

Study Summary

To compare the efficacy of tranexamic acid and diosmin in reducing menstrual blood loss in women having Intra Uterine Contraceptive Device (IUD) and suffer from menorrhagia.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Women complaining from an menorrhagia secondary to a current copper IUD use.

  • Age: 20-40years.

  • Menorrhagia , will be defined as a PBAC-Score greater than 100.

  • No systemic causes of abnormal uterine bleeding as hypertension and hemorrhagic blooddiseases.

  • No other local causes of abnormal uterine bleeding as, (fibroid, adenomyosis, polyps).

  • No drugs decreasing blood coagulation.

  • Well fitted IUD not misplaced.

Exclusion

Exclusion Criteria:

  • Age <20y and >40y.

  • Irregular menstrual cycle.

  • Presence of systemic causes of abnormal uterine bleeding as hypertension andhemorrhagic blood diseases.

  • Presence of other local causes of abnormal uterine bleeding as, (fibroid, adenomyosis,polyps).

  • Taking drugs decrease blood coagulation.

  • Misplaced IUD.

Study Design

Total Participants: 100
Study Start date:
September 01, 2015
Estimated Completion Date:
March 31, 2016

Connect with a study center

  • Ahmed Alanwar

    Cairo, 11331
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.